Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate

 

Granuflo

GranuFlo is an acid concentrate powder used in hemodialysis kidney dialysis, which clears toxic waste from the blood when damaged or failed kidneys can no longer do so.

Granuflo concentrate is manufactured by the German company Fresenius Medical Care (FMC), the largest operator of dialysis clinics and supplier of dialysis products in the world. Each day, FMC treats more than a third of the 400,000 patients who require kidney dialysis in the United States.

Unfortunately, Granuflo has been linked to increased levels of bicarbonate in the blood, which can cause health problems such as:

  • Cardiopulmonary arrest
  • Low blood pressure
  • Stroke
  • Metabolic alkalosis
  • Heart attack and
  • Death

In 2010, FMC noted in studies at their own clinics that Granuflo could cause as much as six times the risk of cardiac arrests and deaths. However, they failed to warn patients, the FDA or thousands of outside dialysis clinics who rely on their products each day.

If you or a loved one suffered cardiopulmonary arrest, heart attack or death after dialysis treatment with Granuflo, it is important to learn your legal options. You may be entitled to compensation for your injuries. Contact us today.

More than 5,700 dialysis centers operate each day in the United States, many with products such as Granuflo supplied by Fresenius Medical Care.

In 2010, FMC conducted a year-long study at its more than 1,000 clinics due to higher-than-normal occurrences of heart problems among patients. The sample trial revealed that 941 patients had suffered cardiopulmonary arrest during that time, which was six times the normal rate.

In November of 2011, FMC sent a memo to its own doctors warning that Granuflo could lead to increased risks of cardiopulmonary arrest or death. However, they did not warn outside clinics, doctors or patients using the concentrate and continued selling it.

Only after the FDA received an anonymous copy of the internal FMC memo was the company required to issue a public warning and recall in March of 2012. As a result, hundreds of thousands of patients were put at risk.

Lawyers are currently helping those who have been affected by cardiopulmonary arrest, heart attack or death from Granuflo file claims for their loss. Due to the number of claims, the litigation is being consolidated to a special federal Multi-District Litigation court.

A lawyer can explain the current litigation involving Granuflo, as well as whether your case may qualify and how long you have to take action.

Before choosing a lawyer, make sure they are qualified for this type of lawsuit and have experience fighting large drug companies. The DrugRisk Resource Center only recommends law firms that specialize in medical device injuries and have handled thousands of claims.

For more information on the warnings, recall and legal action related to Granuflo, or to speak with a lawyer, contact us today. We are available 24 hours a day to provide help.